Your browser version is too low to view empty data. It is recommended to use IE10 (including) above Firefox 、 Google
In case of a key big order, the main force may**
Dig deep into industrial logic and tap the industry leader
In the last 60 days Ganli Pharmaceutical (sh603087) rating was released in three research reports, and the comprehensive rating is as follows:
corporate name:
Ganli Pharmaceutical Co., Ltd
Main business:
R&D, production and sales of recombinant insulin analog APIs and injections.
Telephone: 010-80593699
Fax: 010-60504998
Date of establishment: 1998-06-17
Listing date: 2020-06-29
Legal representative: Gan Zhongru
general manager: Dukai
Registered capital: 601.202 million yuan
Issue price: 63.320 yuan
Latest total share capital: 6012017500 shares
Latest outstanding shares: 10000 shares
Segment: Shanghai A-share Shanghai and Shenzhen A-share Shanghai Stock Exchange Index Shangzheng Medicine Shanghai Stock Connect Innovative medicine Pharmaceutical Biology Biological products Pharmaceutical Biology Other biological products Middish Margin trading
Sign in
Not yet a member of Sina?